Published in Blood on January 01, 1978
Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health (2007) 1.13
A family study of congenital malabsorption of folate. J Inherit Metab Dis (2001) 1.03
Persistent circulating unmetabolised folic acid in a setting of liberal voluntary folic acid fortification. Implications for further mandatory fortification? BMC Public Health (2009) 0.94
Biochemical mechanisms in the Killmann experiment: critique of the deoxyuridine suppression test. J Clin Invest (1980) 0.89
Comparative effect of 6S, 6R and 6RS leucovorin on methotrexate rescue and on modulation of 5-fluorouracil. Br J Cancer (1991) 0.75
Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med (2001) 3.98
French intensivists do not apply American recommendations regarding decisions to forgo life-sustaining therapy. Crit Care Med (2001) 2.39
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol (1986) 1.98
Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Qual Life Res (1996) 1.95
Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON. Lancet (1992) 1.92
Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings. Neurology (1991) 1.86
Myringoplasty by eardrum transplantation. Laryngoscope (1968) 1.52
Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol (1998) 1.44
Treatment of acute myelogenous leukemia. An EBMT-EORTC retrospective analysis of chemotherapy versus allogeneic or autologous bone marrow transplantation. Eur J Cancer Clin Oncol (1989) 1.40
In vitro sensitivity of normal and leukemic myeloid clonogenic cells to hyperthermia: absence of selective effect. Exp Hematol (1989) 1.38
Reconstructive micro-surgery of the eardrum by means of a tympanic membrane homograft. Preliminary report. Acta Otolaryngol (1967) 1.35
Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood (1991) 1.29
Compliance with triage to intensive care recommendations. Crit Care Med (2001) 1.28
Overexpression of cyclin D2 in chronic B-cell malignancies. Blood (1995) 1.26
Aminoglycoside-induced ototoxicity. Toxicol Lett (1990) 1.24
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia (2003) 1.21
Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood (1998) 1.21
Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med (1998) 1.17
The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood (2000) 1.12
Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr (1998) 1.11
Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia (1997) 1.10
Study of folate in psoriasis: blood levels, intestinal absorption and cutaneous loss. Br J Dermatol (1973) 1.08
[Chromosome analyses in idiopathic acquired sideroblastic anemia. A study of 6 cases]. Nouv Rev Fr Hematol (1967) 1.06
Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. Blood (1998) 1.04
Histological study of the thin replacement membrane of human tympanic membrane perforations. Acta Otolaryngol (1988) 1.03
A family study of congenital malabsorption of folate. J Inherit Metab Dis (2001) 1.03
Research on HIV sexual risk: social relations-based approach in a cross-cultural perspective. Soc Sci Med (2000) 1.02
Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood (1999) 1.01
Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol (1999) 0.98
Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency. Eur J Pediatr (1999) 0.98
Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry (1994) 0.97
Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression. Leukemia (1993) 0.96
Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients. J Clin Microbiol (1989) 0.95
[Special problems related to tympano-ossicular homografts]. Acta Otorhinolaryngol Belg (1970) 0.95
Annotation: Subacute and chronic myelomonocytic leukaemia: a distinct haematological entity. Br J Haematol (1976) 0.94
Fournier's gangrene during induction treatment of acute promyelocytic leukemia, a case report. Ann Hematol (1998) 0.94
CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs. J Clin Invest (1998) 0.93
Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp Epidemiol (1999) 0.93
Topics in physics and middle ear surgery. Acta Otorhinolaryngol Belg (1973) 0.92
Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity. J Immunol Methods (2000) 0.92
[Neonatal hemolytic-uremic syndrome, methylmalonic aciduria and homocystinuria caused by intracellular vitamin B 12 deficiency. Value of etiological diagnosis]. Arch Fr Pediatr (1993) 0.92
MDR1/P-glycoprotein in haematological neoplasms. Eur J Cancer (1996) 0.91
[Influence of intrinsic factor deficiency on malabsorption of vitamin B12 bound to proteins in achlorhydria]. Gastroenterol Clin Biol (1982) 0.91
Human middle ear transplants. J Laryngol Otol (1971) 0.90
Modern clinical testing strategies in cobalamin and folate deficiency. Semin Hematol (1999) 0.90
[Diagnosis of conduction deafness caused by ear injury]. Acta Otorhinolaryngol Belg (1971) 0.89
Waldenström's macroglobulinaemia in a bird breeder: a case history with pulmonary involvement and antibody activity of the monoclonal IgM to canary's droppings. Clin Exp Immunol (1987) 0.89
Letter: HL-A and pernicious anemia. N Engl J Med (1975) 0.89
Spontaneous remission in adult acute leukemia. Cancer (1985) 0.88
A technique of anaesthesia, especially adapted for ear surgery, "protected sleep". Acta Otolaryngol Suppl (1971) 0.88
Control of erythropoiesis in humans during prolonged exposure to the altitude of 6,542 m. Am J Physiol (1994) 0.88
[Waldenstrôm's macroglobulinemia. Developmental and prognostic study]. Sem Hop (1975) 0.88
Homoharringtonine: an effective new natural product in cancer chemotherapy. Bull Cancer (1995) 0.88
[Narco-neuroleptoanalgesia in otorhinolaryngology]. Anesth Analg (Paris) (1966) 0.88
Prediction of the response to chemotherapy in acute leukemia. Cancer (1975) 0.87
N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin. Bone Marrow Transplant (1993) 0.87
Experiences with tympanic transplants. Arch Otolaryngol (1973) 0.87
Disseminated superficial porokeratosis after autologous bone marrow transplantation. Bone Marrow Transplant (1997) 0.87
The incudo-malleal joint. J Laryngol Otol (1981) 0.87
Folate, vitamin B12, and HIV infection. Lancet (1990) 0.86
Methylenetetrahydrofolate reductase thermolabile variant and human longevity. Am J Hum Genet (1997) 0.86
Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia. Leukemia (1987) 0.86
[Subacute myelo-monocytic leukemia. Study of 27 cases and review of the literature]. Sem Hop (1972) 0.85
Normal human bone marrow cultures in vitro: cellular composition and maturation of the granulocytic colonies. Br J Haematol (1977) 0.85
Tuberculosis in the middle ear: 5 case reports. Acta Otorhinolaryngol Belg (1989) 0.85
Splenic marginal zone lymphoma with or without plasmacytic differentiation. Am J Surg Pathol (2000) 0.85
Maternal folate status, birthweight and gestational age. Dev Pharmacol Ther (1982) 0.85
[Pseudolymphoma and lymphoproliferative syndromes in Gougerot-Sjögren syndrome (author's transl)]. Sem Hop (1979) 0.85
A modular questionnaire for the assessment of longterm quality of life in leukaemia patients: the MRC/EORTC QLQ-LEU. Qual Life Res (1996) 0.85
Pregnancy during myelosuppressive treatment for chronic myelogenous leukemia. Br J Haematol (1992) 0.85
[Hemolysis and schizocytosis, malabsorption and the "folate trap": unusual semiological peculiarities associated with vitamin B12 deficiency]. Rev Med Interne (1998) 0.85
Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br J Haematol (1996) 0.85
Sphenoid sinus localization of multiple myeloma revealing evolution from benign gammopathy. Head Neck (1997) 0.84
Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. Br J Haematol (1994) 0.84
Dehiscence of the facial canal: developmental aspects. Int J Pediatr Otorhinolaryngol (1991) 0.84
Congenital malformations and middle ear surgery. J R Soc Med (1981) 0.84
European undergraduate education in oncology. A report of the EORTC Education Branch. Acta Oncol (1988) 0.84
The three transcobalamins in myeloproliferative disorders and acute leukaemia. Br J Haematol (1975) 0.84
Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia (1992) 0.84
Delayed complication of a rib fracture. Phys Sportsmed (1998) 0.84
Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. Blood (1984) 0.83
[Value of vitamin B 12 assay in presumed degenerative dementia]. Presse Med (1989) 0.83
Folate metabolism disorder in Kearns-Sayre syndrome. Ann Neurol (1983) 0.83